Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Amylase concentration linked to mortality in guinea pigs
Researchers say the digestive enzyme is often overlooked.
Guinea pigs with high plasma concentrations of amylase face increased mortality.

Researchers have revealed the clinical significance of plasma amylase to the lifespan of guinea pigs.

The new study has found that guinea pigs which recorded particularly high plasma concentrations of amylase were more likely to die within 30 days of biochemistry analysis.

To investigate the causes of mortality in guinea pigs, researchers retrospectively analysed the medical records of 278 guinea pigs treated in four different institutions. The guinea pigs had all undergone a biochemistry panel, had their plasma concentrations measured and had a follow-up 30 days later.

The guinea pigs had been brought to the institutions for a number of reasons, including emergencies, sickness and wellness appointments. Among their diagnoses were integument disease, reproductive issues and gastrointestinal disease.

Using this data, the research team analysed the guinea pigs’ survival rates and drew comparisons to their amylase concentrations.

The analysis revealed that guinea pigs which recorded an elevated level of plasma amylase concentration (1910 to 3985 U/L) were seven times more likely to die in the next 30 days than those with a concentration within the reference intervals (1339 to 1573 U/L).

It also found increased mortality risk among guinea pigs with high blood urea nitrogen (BUN) concentrations. Guinea pigs with BUN concentrations higher 62 mg/dL had a 30 times increase in their mortality risk.

Ashley Souza and Sarah Ozawa, lead authors of the study, said: “Guinea pigs can be a challenging species to treat, especially when they enter a veterinary hospital in critical condition.

“It is our hope that this study provides further diagnostic tools for veterinarians to use when explaining options and prognosis to an owner, helping guide treatment and care for this species.”

Amylase is a digestive enzyme, which researchers say is often overlooked. Its clinical significance is largely misunderstood, however researchers now say that high amylase levels could indicate a sick guinea pig requires more diagnostic testing or supportive care.

The researchers say that, because the prognostic capacity of amylase is limited, the amylase concentration data should only be used as part of the bigger clinical picture and should not solely inform veterinary decisions.

The full study can be found in the Journal of Small Animal Practice.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.